Baird Reduces PT on Elevance Health (ELV) Stock, Maintains Neutral
Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds.
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 3,200,146 | $1,244,728,893 | -2% | 2.44% |
| 2. | Yacktman Asset Management Donald Yacktman | 341,340 | $132,767,606 | -1% | 1.78% |
| 3. | High Ground Investment Management Edgar Allen | 242,842 | $94,455,824 | +10% | 19.8% |
| 4. | Pzena Investment Management Richard S. Pzena | 217,276 | $84,511,673 | +9% | 0.27% |
| 5. | Hosking Partners Jeremy Hosking | 77,075 | $29,979,092 | -1% | 1.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $287.96 | 1,050 | $302,358.00 | 151,020 | 2025-07-18 | Filing | |
| $287.12 | 5,116 | $1,468,905.92 | 149,970 | 2025-07-18 | Filing | |
| $286.07 | 2,334 | $667,687.38 | 144,854 | 2025-07-18 | Filing | |
| $384.36 | 1,300 | $499,668.00 | 4,714 | 2021-07-23 | Filing | |
| $296.03 | 1,700 | $503,251.00 | 2,921 | 2021-02-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $424.82 | 4,588 | $1,949,074.16 | 18,977 | 2025-04-24 | Filing | |
| $415.13 | 443 | $183,902.59 | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | $1,388,635.20 | 10,116 | 2025-03-05 | Filing | |
| $432.14 | 7,417 | $3,205,182.38 | 8,423 | 2024-10-18 | Filing | |
| $531.52 | 753 | $400,234.56 | 8,744 | 2024-08-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,825,208 | $2,265,772,904 | 3.04% | |
| 2. | 5,093,882 | $1,977,050,867 | 0.14% | |
| 3. | 2,328,610 | $905,736,145 | 0.29% | |
| 4. | 2,237,022 | $870,112,077 | 0.65% | |
| 5. | 1,300,818 | $505,965,970 | 0.1% |
News See All
UBS Affirms Elevance Health’s (ELV) ‘Buy’ Rating on Earning Stability and Growth Prospects
Elevance Health, Inc. (NYSE:ELV) is one of the best depressed stocks to buy in 2025. On July 28, UBS reiterated a ‘Buy’ rating on the stock and a $435 price target.
11 Most Undervalued Long Term Stocks to Buy According to Hedge Funds
BlackRock sees risk assets in a tug-of-war between strong US corporate earnings, driven by the AI theme, and tariffs that impact growth while increasing inflation.
Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs
Elevance Health, Inc. (NYSE:ELV) is a major U.S. healthcare company, known for its insurance brands Anthem and WellPoint, and its growing Carelon health services arm.
Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty
Elevance Health, Inc. (NYSE:ELV) ranks among the best magic formula stocks to invest in. Wells Fargo kept its Overweight rating on Elevance Health, Inc.
10 Most Undervalued Healthcare Stocks to Buy According to Analysts
The CEO of Pivotal Advisors, Tiffany McGhee, spoke on CNBC on June 27 on what investors should do in light of the current state of the market.
Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings
In its earnings release, Elevance Health, Inc.
Elevance Health, Inc. (ELV): I Won't Touch It With A 10 Foot Pole, Says Jim Cramer
Elevance Health, Inc. (NYSE:ELV) is one of the biggest healthcare benefits companies in America. Its shares have dipped by 24% year-to-date, primarily on the back of a 19% dip in July.
15 Best Magic Formula Stocks to Invest In
Joel Greenblatt's legacy as an investor is based on his ability to spot opportunities where most others can't.
Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the disinflationary effects of AI.
Billionaire Hedge Funds
